Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05253703
Other study ID # Pro2021002091
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 16, 2022
Est. completion date June 7, 2022

Study information

Verified date August 2022
Source Rutgers, The State University of New Jersey
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study has four objectives about healthy younger and older adults during immersive virtual reality bicycling: Determine the effect of visual feedback and competition for younger healthy adults during virtual bicycling on user experience, motivation, enjoyment, perception of effort, and neuromuscular and cardiovascular intensity Determine the effect of visual feedback and competition for older healthy adults during virtual bicycling on user experience, motivation, enjoyment, perception of effort, and neuromuscular and cardiovascular intensity Compare younger and older during visual feedback and competition bicycling in terms of: user experience, motivation, enjoyment, perception of effort, neuromuscular and cardiovascular intensity Determine if attention differs in visual feedback bicycling compared to competition bicycling for younger and older healthy adults


Description:

Participants will attend one session lasting about 1.5 hours. They will complete a competitiveness assessment and a questionnaire about physical activity. They will then exercise in three different virtual reality augmented bicycling conditions while wearing a head mounted display (goggles). Each of the three conditions will last approximately 5 minutes and will be followed by questionnaires about the participant's experience.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date June 7, 2022
Est. primary completion date June 7, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 75 Years
Eligibility Inclusion Criteria: - 21-75 years old, - Able to ride a stationary upright bicycle, - Able to sign informed consent. Exclusion Criteria: - Have a recent history of severe heart disease, severe lung disease, uncontrolled diabetes, traumatic brain injury or any other neurological disorder - Are unable to follow directions or sign a consent form, - Do not have adequate vision or hearing ability to see or hear a television, - Have unstable medical condition or musculoskeletal disorder such as severe arthritis, recent knee surgery, hip surgery, or any other condition that the investigators determine would impair the ability to ride the bicycle, - Have any other medical condition that prevents bicycling, - Have moderate depression (score of 10 or more on PHQ-9 screening tool)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Virtual reality bicycling
This is a single arm study in which all participants will execute the same three bicycling tasks over one session (see arm/group description).

Locations

Country Name City State
United States Rutgers School of Health Professions Newark New Jersey

Sponsors (1)

Lead Sponsor Collaborator
Rutgers, The State University of New Jersey

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other International Physical Activity Questionnaire (IPAQ) The IPAQ is a 27-item questionnaire to measure levels of physical activity. There are 4 main domains of physical activity related to: occupation, transportation, housework, leisure activity. Scores range from 0-19,278 with higher scores representing higher levels of physical activity over the past 7 days. Collected once at start of the session
Other Patient Health Questionnaire (PHQ-9) The PHQ-9 is a 9-item questionnaire to rate depression (scored from 0-27 with a lower score indicating lower levels of depression). Collected once during screening
Primary Neuromuscular Intensity (Bicycling cadence, revolutions per minute) - Feedback Bicycling cadence collected continuously (1 value per second, 1 Hz) Session 1 - During the 5-minute feedback bout
Primary Neuromuscular Intensity (Bicycling cadence, revolutions per minute) - Self-Competition Bicycling cadence collected continuously (1 value per second, 1 Hz) Session 1 - During the 5-minute self-competition bout
Primary Neuromuscular Intensity (Bicycling cadence, revolutions per minute) - Other-Competition Bicycling cadence collected continuously (1 value per second, 1 Hz) Session 1 - During the 5-minute other-competition bout
Primary Motivation (Intrinsic Motivation Inventory) - Feedback Intrinsic Motivation Inventory - enjoyment, competence, effort, and value subscales (16 questions total). Scores in each subscale are averaged, with a minimum score of 1 and a maximum score of 7. Higher scores indicate higher motivation. Session 1 - Immediately after completing the 5-minute feedback bout
Primary Motivation (Intrinsic Motivation Inventory) - Self-Competition Intrinsic Motivation Inventory - enjoyment, competence, effort, and value subscales (16 questions total). Scores in each subscale are averaged, with a minimum score of 1 and a maximum score of 7. Higher scores indicate higher motivation. Session 1 - Immediately after completing the 5-minute self-competition bout
Primary Motivation (Intrinsic Motivation Inventory) - Other-Competition Intrinsic Motivation Inventory - enjoyment, competence, effort, and value subscales (16 questions total). Scores in each subscale are averaged, with a minimum score of 1 and a maximum score of 7. Higher scores indicate higher motivation. Session 1 - Immediately after completing the 5-minute other-competition bout
Primary Cardiovascular Intensity (Heart rate, beats per minute) - Feedback Heart rate collected continuously (1 value per second, 1 Hz) Session 1 - During the 5-minute feedback bout
Primary Cardiovascular Intensity (Heart rate, beats per minute) - Self-Competition Heart rate collected continuously (1 value per second, 1 Hz) Session 1 - During the 5-minute self-competition bout
Primary Cardiovascular Intensity (Heart rate, beats per minute) - Other-Competition Heart rate collected continuously (1 value per second, 1 Hz) Session 1 - During the 5-minute other-competition bout
Primary Visual Attention (infrared eye-tracking data representing gaze positions in a 3D coordinate plane to be used in calculating dwell time in regions of interest in the virtual simulation) - Feedback 3D gaze positions measured continuously (50 values per second, 50 Hz) Session 1 - During the 5-minute feedback bout
Primary Visual Attention (infrared eye-tracking data representing gaze positions in a 3D coordinate plane to be used in calculating dwell time in regions of interest in the virtual simulation) - Self-Competition 3D gaze positions measured continuously (50 values per second, 50 Hz) Session 1 - During the 5-minute self-competition bout
Primary Visual Attention (infrared eye-tracking data representing gaze positions in a 3D coordinate plane to be used in calculating dwell time in regions of interest in the virtual simulation) - Other-Competition 3D gaze positions measured continuously (50 values per second, 50 Hz) Session 1 - During the 5-minute other-competition bout
Secondary Rating of Perceived Exertion - Feedback (start) Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts. The score ranges from 6-20 with higher scores representing higher perceived exertion. Session 1 - Immediately at the start (0-minute mark) of the 5-minute feedback bout
Secondary Rating of Perceived Exertion - Feedback (middle) Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts. The score ranges from 6-20 with higher scores representing higher perceived exertion. Session 1 - At the midpoint (2.5-minute mark) of the 5-minute feedback bout
Secondary Rating of Perceived Exertion - Feedback (end) Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts. The score ranges from 6-20 with higher scores representing higher perceived exertion. Session 1 - At the endpoint (5-minute mark) of the 5-minute feedback bout
Secondary Rating of Perceived Exertion - Self-Competition (start) Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts. The score ranges from 6-20 with higher scores representing higher perceived exertion. Session 1 - Immediately at the start (0-minute mark) of the 5-minute self-competition bout
Secondary Rating of Perceived Exertion - Self-Competition (middle) Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts. The score ranges from 6-20 with higher scores representing higher perceived exertion. Session 1 -At the midpoint (2.5-minute mark) of the 5-minute self-competition bout
Secondary Rating of Perceived Exertion - Self-Competition (end) Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts. The score ranges from 6-20 with higher scores representing higher perceived exertion. Session 1 -At the end (5-minute mark) of the 5-minute self-competition bout
Secondary Rating of Perceived Exertion - Other-Competition (start) Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts. The score ranges from 6-20 with higher scores representing higher perceived exertion. Session 1 -Immediately at the start (0-minute mark) of the 5-minute other-competition bout
Secondary Rating of Perceived Exertion - Other-Competition (middle) Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts. The score ranges from 6-20 with higher scores representing higher perceived exertion. Session 1 -At the midpoint (2.5-minute mark) of the 5-minute other-competition bout
Secondary Rating of Perceived Exertion - Other-Competition (end) Borg scale measures a self-report of effort collected at multiple time points to compare the 3 exercise bouts. The score ranges from 6-20 with higher scores representing higher perceived exertion. Session 1 -At the end (5-minute mark) of the 5-minute other-competition bout
Secondary Competitiveness (Multidimensional Competitive Orientation Inventory) Measured once using the Multidimensional Competitive Orientation Inventory consisting of 12 items from 4 subscales (hyper competitive, self-developmental, anxious, lack of interest) For each subscale, mean scores range from 1-6 with higher scores representing higher levels of that subscale metric. Session 1 - Collected once at start of session
Secondary Ranking of Perceived Effort Once, after completing all 3 bicycling conditions, participants will be asked in which of the 3 bicycling conditions they felt they worked the hardest. They will rank the 3 conditions with a score from 1-3, with a 1 indicating the condition in which they felt they worked the hardest and a 3 indicating the condition in which they felt they worked the least hard. Session 1 - once at the end of the session. Collected upon study completion, immediately after finishing the final bicycling condition
Secondary Ranking of Enjoyment Once, after completing all 3 bicycling conditions, participants will be asked which of the 3 bicycling conditions they liked the best. They will rank the 3 conditions with a score from 1-3, with a 1 indicating the condition they liked the best and a 3 indicating the condition they liked the least. Session 1 - once at the end of the session. Collected upon study completion, immediately after finishing the final bicycling condition
Secondary Audio recordings of exercise experience Once, after completing all 3 bicycling conditions, participants will be asked about their exercise experience. Their responses will be audio recorded to be coded and analyzed qualitatively for themes. Session 1 - once at the end of the session. Collected upon study completion, immediately after finishing the final bicycling condition
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1